av/connect-biopharma-limited--big.svg

NASDAQ:CNTB

Connect Biopharma Holdings Limited American Depositary Shares

  • Stock

USD

Last Close

1.36

26/07 20:00

Market Cap

68.88M

Beta: −0.54

Volume Today

20.54K

Avg: 344.89K

PE Ratio

−0.56

PFCF: −0.63

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-168.63M
-
-779.23M
362.11%
-1.31B
67.49%
-795.02M
39.09%
-59.38M
92.53%
depreciation and amortization
790K
-
1.44M
82.66%
4.08M
182.88%
6.94M
70.01%
988K
85.76%
deferred income tax
57.23M
-
585.39M
922.85%
677.39M
15.72%
23.04M
96.60%
-272K
101.18%
stock based compensation
3.88M
-
25.19M
550.06%
57.86M
129.71%
45.60M
21.20%
3.26M
92.85%
change in working capital
16.42M
-
-2.85M
117.34%
20.82M
831.04%
49.02M
135.46%
9.48M
80.65%
accounts receivables
-3.03K
-
-9.35K
208.99%
-16.12K
72.36%
23.08K
243.24%
inventory
3.03K
-
9.35K
208.99%
16.12K
72.36%
-23.08K
243.24%
accounts payables
19.35M
-
1.85M
90.44%
56.60M
2,959.51%
2.57M
95.46%
-4.28M
266.29%
other working capital
-2.93M
-
-4.70M
60.29%
-35.78M
661.62%
46.45M
229.82%
13.76M
70.37%
other non cash items
53K
-
2.89M
5,358.49%
44K
98.48%
-9.25M
21,118.18%
-2.01M
78.30%
net cash provided by operating activities
-90.26M
-
-167.16M
85.21%
-544.93M
225.99%
-679.66M
24.73%
-47.93M
92.95%
investments in property plant and equipment
-1.07M
-
-15.30M
1,327.61%
-47.53M
210.57%
-29.32M
38.31%
-294K
99.00%
acquisitions net
2.27K
-
349K
15,281.23%
304K
12.89%
541.99K
78.29%
2.94M
443.00%
purchases of investments
-163M
-
-106.60M
34.60%
-114.50M
7.41%
-778.49M
579.91%
-32.60M
95.81%
sales maturities of investments
160.73M
-
124.84M
22.33%
128.00M
2.54%
236.50M
84.76%
105.19M
55.52%
other investing activites
-2.27K
-
-349K
15,281.23%
-304K
12.89%
-541.99K
78.29%
-84K
84.50%
net cash used for investing activites
-3.34M
-
2.93M
187.76%
-34.02M
1,260.47%
-571.31M
1,579.09%
75.16M
113.15%
debt repayment
-445K
-
-538K
20.90%
-805K
49.63%
-1.51M
88.20%
-290K
80.86%
common stock issued
1.43B
-
132K
99.99%
44K
66.67%
common stock repurchased
-3.67M
-
dividends paid
-243K
-
other financing activites
49K
-
919.30M
1,876,020.41%
-110.95M
112.07%
758K
100.68%
net cash used provided by financing activities
-396K
-
918.76M
232,110.35%
1.32B
43.25%
-625K
100.05%
-246K
60.64%
effect of forex changes on cash
1.37M
-
-53.43M
4,005.56%
-40.34M
24.49%
94.99M
335.46%
18K
99.98%
net change in cash
-92.63M
-
701.10M
856.93%
696.80M
0.61%
-1.16B
265.99%
27.00M
102.33%
cash at beginning of period
401.60M
-
308.97M
23.06%
1.01B
226.92%
1.71B
68.99%
79.01M
95.37%
cash at end of period
308.97M
-
1.01B
226.92%
1.71B
68.99%
550.27M
67.76%
106.01M
80.74%
operating cash flow
-90.26M
-
-167.16M
85.21%
-544.93M
225.99%
-679.66M
24.73%
-47.93M
92.95%
capital expenditure
-1.07M
-
-15.30M
1,327.61%
-47.53M
210.57%
-29.32M
38.31%
-294K
99.00%
free cash flow
-91.33M
-
-182.47M
99.79%
-592.46M
224.70%
-708.99M
19.67%
-48.22M
93.20%

All numbers in USD (except ratios and percentages)